Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Leukoencephalopathy, Progressive Multifocal
0.100 AlteredExpression disease BEFREE Finally, elevated levels of PML-NB, PML protein and PML mRNA were detected in the brain tissues from Alzheimer's disease (AD) patients, where γ-secretase activity is essential for pathogenesis. 23306558 2013
Leukoencephalopathy, Progressive Multifocal
0.100 Biomarker disease BEFREE Fluorescence in situ hybridization with a PML/RARA dual-color DNA probe showed the fusion signals on der(15) and the residual PML signals on der(22). 16737919 2006
Leukoencephalopathy, Progressive Multifocal
0.100 Biomarker disease BEFREE Promyelocytic leukemia (PML) has been implicated in a variety of functions, including control of TP53 function and modulation of cellular senescence. 16778193 2006
Leukoencephalopathy, Progressive Multifocal
0.100 Biomarker disease BEFREE Gene Knockout Shows That PML (TRIM19) Does Not Restrict the Early Stages of HIV-1 Infection in Human Cell Lines. 28656178 2019
Leukoencephalopathy, Progressive Multifocal
0.100 Biomarker disease BEFREE Promyelocytic leukemia (PML) nuclear bodies (NBs) induce latent/quiescent HSV-1 genomes chromatinization through a PML NB/Histone H3.3/H3.3 Chaperone Axis. 30235352 2018
Leukoencephalopathy, Progressive Multifocal
0.100 Biomarker disease BEFREE The promyelocytic leukemia (PML) protein is the core component of nuclear substructures that host more than 70 proteins, termed nuclear domains 10 or PML-nuclear bodies. 21501958 2011
Leukoencephalopathy, Progressive Multifocal
0.100 AlteredExpression disease BEFREE In conclusion, the expression of proto-oncogene PML and HLA class I molecules were concordantly upregulated and the expression of PML gene might be one of the mechanisms that leads to the increased expression of class I antigen in HCC. 17767548 2007
Leukoencephalopathy, Progressive Multifocal
0.100 Biomarker disease BEFREE Infected cells pretreated with siX3, but not siUL54, retained promyelocytic leukemia (PML) protein in cellular PML bodies, an essential component of this host intrinsic antiviral defense. 22438545 2012
Leukoencephalopathy, Progressive Multifocal
0.100 AlteredExpression disease BEFREE To test this hypothesis, we used a series of ICP0 truncation mutants and examined PML protein levels and PML and Sp100 immunofluorescence staining in human embryonic lung cells. 24089549 2013
Leukoencephalopathy, Progressive Multifocal
0.100 Biomarker disease BEFREE ALT associated PML bodies containing PML protein was found in telomerase negative cases of RCC. 25769384 2015
Leukoencephalopathy, Progressive Multifocal
0.100 Biomarker disease BEFREE The results suggest that EBNA1 usurps two host PML regulators in order to promote degradation of PML proteins and loss of PML NBs. 21217204 2011
Leukoencephalopathy, Progressive Multifocal
0.100 Biomarker disease BEFREE We investigated the imaging characteristics of inflammatory NTZ-PML lesions and PML-IRIS to determine differentiating and overlapping features. 29142146 2018
Leukoencephalopathy, Progressive Multifocal
0.100 Biomarker disease BEFREE Promyelocytic leukemia (PML) is a tumor suppressor and proapoptotic factor. 26703467 2016
Leukoencephalopathy, Progressive Multifocal
0.100 Biomarker disease BEFREE The Promyelocytic leukemia protein (PML) tumor suppressor is upregulated in several forms of cellular senescence, however the mechanism of its induction is elusive. 20699642 2010
Leukoencephalopathy, Progressive Multifocal
0.100 Biomarker disease BEFREE Overall our study designates PML protein and PML-NBs to be major cellular components involved in the control of HSV-1 latency, probably during the entire life of an individual. 27618691 2016
Leukoencephalopathy, Progressive Multifocal
0.100 Biomarker disease BEFREE As a result, methyl 2,5-dihydromethylcinnimate (2,5-MeC), a tyrosine kinase inhibitor, enhanced expression and/or stability of PML proteins and induced PML-NB formation in p53 null H1299 cells established from non-small cell lung cancer (NSCLC) and wild-type p53-expressing U2OS cells derived from osteosarcoma. 17585903 2007
Leukoencephalopathy, Progressive Multifocal
0.100 Biomarker disease BEFREE Using two different human neuroblastoma cell lines, SH-SY5Y and LA-N-5, we show here that PML protein leads to the formation of nuclear bodies (PML-NB) after only 1 h of retinoic acid treatment and that this formation is mediated by the extracellular signal-regulated kinase (ERK) pathway. 17986232 2008
Leukoencephalopathy, Progressive Multifocal
0.100 AlteredExpression disease BEFREE PML-regulated apoptotic mechanisms in GBM cells transfected with plasmids expressing the PML gene were examined. 18812519 2009
Leukoencephalopathy, Progressive Multifocal
0.100 Biomarker disease BEFREE The hallmark reciprocal chromosomal translocation t(15;17) involving fusion between the retinoic acid receptor (RARα) gene and promyelocytic leukemia (PML) gene is a characteristic feature in APL which consequently results in the emergence of PML-RARα chimeric gene. 29700805 2019
Leukoencephalopathy, Progressive Multifocal
0.100 Biomarker disease BEFREE Progressive multifocal leukoencephalopathy [PML], a brain infection associated with anti-integrin drugs that inhibit lymphocyte translocation from bloodstream to tissue, can be fatal. 28961770 2018
Leukoencephalopathy, Progressive Multifocal
0.100 Biomarker disease BEFREE In human cytomegalovirus (HCMV) infection, the IE1 (for "immediate-early 1") protein has a marked effect on PML bodies via de-SUMOylation of PML protein. 16870775 2006
Leukoencephalopathy, Progressive Multifocal
0.100 Biomarker disease BEFREE An immunohistochemical study of PML protein in these tumors revealed a disrupted pattern of PML bodies in a nuclear diffuse form, as observed in APL cells. 15104675 2004
Leukoencephalopathy, Progressive Multifocal
0.100 Biomarker disease BEFREE The occurrence of HIPK domains in PML-/- fibroblasts reveals their independence from the PML protein. 12907596 2003
Leukoencephalopathy, Progressive Multifocal
0.100 Biomarker disease BEFREE In this study, we uncover a novel mechanism of PML gene regulation in which the p38 MAPK and its downstream kinase MAP kinase-activated protein kinase 1 (MNK1) mediate TNFα-induced PML protein accumulation and PML NB formation. 26383972 2016
Leukoencephalopathy, Progressive Multifocal
0.100 Biomarker disease BEFREE Promyelocytic leukemia (PML) nuclear bodies (NBs) recruit partner proteins, including p53 and its regulators, thereby controlling their abundance or function. 28931625 2017